世界の電子処方箋（eRx）市場...市場調査レポートについてご紹介

TABLE OF CONTENTS

1 INTRODUCTION
1.1 KEY TAKE-AWAYS
1.2 REPORT DESCRIPTION
1.3 MARKETS COVERED
1.4 STAKEHOLDERS
1.5 RESEARCH METHODOLOGY
1.5.1 MARKET SIZE
1.5.2 KEY DATA POINTS FROM SECONDARY SOURCES
1.5.3 KEY DATA POINTS FROM PRIMARY SOURCES
1.5.4 ASSUMPTIONS

2 EXECUTIVE SUMMARY

3 MARKET OVERVIEW
3.1 E-PRESCRIBING SYSTEM
3.1.1 ERX PROCESS
3.1.2 PRESCRIBER
3.1.3 TRANSACTION HUB
3.1.4 PHARMACY
3.1.5 PHARMACY BENEFIT MANAGER
3.2 MARKET SEGMENTATION
3.2.1 DRIVERS
3.2.1.1 GOVERNMENT INITIATIVES & INCENTIVE PROGRAMS CONTRIBUTE TO THE GROWTH OF ERX SYSTEMS ACROSS THE GLOBE
3.2.1.2 THE MIPPA ERX INCENTIVE PROGRAMME LAUNCHED BY MEDICARE SPUR THE ADOPTION OF ERX SYSTEMS
3.2.1.3 ERX LEADS TO SIGNIFICANT SAVINGS FOR THE HEALTHCARE INDUSTRY
3.2.1.4 BETTER QUALITY OF HEALTHCARE AND MINIMIZATION OF ERRORS
3.2.2 RESTRAINTS
3.2.2.1 PHYSICIAN’S RELUCTANCE TO ADOPTION OF TECHNOLOGY
3.2.2.2 POOR INFRASTRUCTURE INTENSIFIES COMPLICATIONS
3.2.2.3 FINANCIAL CONSTRAINTS DUE TO ADDED COSTS AS COMPARED TO TRADITIONAL PRESCRIPTION SYSTEMS
3.2.3 OPPORTUNITY
3.2.3.1 INCREASED COLLABORATION BETWEEN SOFTWARE VENDORS AND NETWORK PROVIDERS TO OFFER COST EFFICIENT PRODUCTS IN THE MARKET
3.2.4 MARKET SHARE ANALYSIS, BY KEY PLAYERS

4 BENEFITS & CHALLENGES OF E-PRESCRIBING SYSTEMS
4.1 BENEFITS OF E-PRESCRIBING
4.1.1 IMPROVED PATIENT SAFETY & QUALITY OF CARE
4.1.2 REDUCES THE TIME REQUIRED TO COMMUNICATE WITH PHARMACIES
4.1.3 AUTOMATED RENEWAL REQUEST & AUTHORIZATION PROCESS
4.1.4 CONNECTS WITH THE ENTIRE HEALTHCARE DELIVERY PROCESS
4.2 CHALLENGES FOR E-PRESCRIBING
4.2.1 COSTS OF IMPLEMENTATION & RETURNS
4.2.2 RESISTANCE TO CHANGE
4.2.3 HARDWARE & SOFTWARE SELECTION
4.2.4 SECURITY & PRIVACY
4.2.5 SYSTEM DOWNTIME

5 GLOBAL E-PRESCRIPTION MARKET, BY PRODUCT TYPE
5.1 INTRODUCTION
5.1.1 STAND-ALONE SYSTEMS
5.1.2 INTEGRATED SYSTEMS
5.1.3 COST COMPONENTS OF AN E-PRESCRIBING SYSTEM

6 GLOBAL E-PRESCRIBING MARKET, BY COMPONENT
6.1 INTRODUCTION
6.2 SOFTWARE
6.3 HARDWARE
6.3.1 ACCESS DEVICES
6.3.2 PERIPHERALS
6.3.3 SERVERS
6.3.4 STORAGE DEVICES
6.3.5 NETWORKING DEVICES
6.4 SERVICES
6.4.1 CONSULTING
6.4.2 IMPLEMENTATION SERVICES
6.4.3 POST-SALE & MAINTENANCE
6.4.4 TRAINING SERVICES

7 GLOBAL E-PRESCRIBING MARKET, BY DELIVERY MODE
7.1 INTRODUCTION
7.2 ON-PREMISE
7.3 WEB-BASED
7.3.1 BENEFIT OF WEB-BASED DELIVERY MODEL
7.3.1.1 ANYTIME, ANYWHERE ACCESS AT REDUCED COST
7.4 CLOUD
7.4.1 CLOUD SET TO GROW AS THE MOST PREFERRED DELIVERY MODEL

8 GLOBAL E-PRESCRIBING MARKET, BY USAGE MODE
8.1 INTRODUCTION
8.2 PC-BASED
8.3 HAND-HELD

9 GLOBAL E-PRESCRIBING MARKET, BY END-USER
9.1 INTRODUCTION
9.2 HOSPITALS
9.3 OFFICE-BASED PHYSICIANS

10 E-PRESCRIPTION MARKET, BY GEOGRAPHY
10.1 INTRODUCTION
10.2 NORTH AMERICA
10.2.1 U.S.
10.2.2 CANADA
10.2.2.1 PRIVACY CONSIDERATIONS AFFECT GROWTH OF ERX MARKET IN CANADA
10.3 EUROPE
10.3.1 EUROPEAN EMR ADOPTION MODEL
10.3.1.1 U.K.
10.3.1.2 DENMARK
10.3.1.3 SWEDEN
10.3.1.4 THE NETHERLANDS
10.3.1.5 FRANCE
10.3.1.6 ROE
10.4 ASIA-PACIFIC
10.5 ROW

11 COMPETITIVE LANDSCAPE
11.1 INTRODUCTION
11.2 MERGERS & ACQUISITIONS
11.3 COLLABORATIONS/PARTNERSHIPS/AGREEMENTS/JOINT VENTURES 139
11.4 NEW PRODUCT DEVELOPMENTS/PRODUCT MODIFICATION
11.5 OTHERS

12 COMPANY PROFILES(OVERVIEW, FINANCIALS, PRODUCTS & SERVICES, STRATEGY, AND DEVELOPMENTS)*
12.1 ABEL MEDICAL SOFTWARE, INC.
12.2 ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.
12.3 ATHENAHEALTH, INC.
12.4 BIZMATICS, INC.
12.5 CERNER CORPORATION
12.6 DRFIRST, INC.
12.7 ECLINICALWORKS, LLC
12.8 EMDEON, INC.
12.9 E-MDS, INC.
12.10 IMEDX, INC.
12.11 INSTANTDX, LLC (A SUBSIDIARY OF IMMUNOMATRIX, INC.).
12.12 HENRY SCHEIN MEDICAL SYSTEM, INC. (A SUBSIDIARY OF HENRY SCHEIN, INC.)
12.13 NEWCROPRX, LLC
12.14 PRACTICE FUSION, INC.
12.15 QUALITY SYSTEM, INC.
12.16 SURESCRIPTS-RXHUB, LLC
*DETAILS ON FINANCIALS, PRODUCT & SERVICES, STRATEGY, AND DEVELOPMENTS MIGHT NOT BE CAPTURED IN CASE OF UNLISTED COMPANIES.